Copy
October: Educate About ILC
 
October is Breast Cancer Awareness month.  Please join LBCA to educate about the Signs of Lobular Breast Cancer - the second most common cellular type of breast cancer that alone is the 6th most frequently diagnosed cancer of women in the U.S.  Help spread the word with your networks about a subtype of breast cancer that most have never heard of, is understudied and needs more research to refine therapies for patients.

 

Spread the Word about ILC

A new research consortium in the European Union seeks to increase collaboration and advance research into therapies for patients with lobular breast cancer (ILC).

The European Lobular Breast Cancer Consortium (ELBCC) plans its next consortium meeting at the KU Leuven (25th of November), where they will discuss ILC clinical trial and funding options. Patient advocates will attend and contribute to the ELBCC meeting.

Learn More
Webinar:  Metastatic Lobular Breast Cancer
 Join Lobular Breast Cancer Alliance (LBCA) Scientific Advisory Board members Dr. Rachel Jankowitz, medical oncologist at the University of Pennsylvania Medical Center, and Dr. Gary Ulaner, radiologist at Memorial Sloan Kettering Cancer Center, to discuss what we are learning about ILC metastasis, imaging options and promising therapies. LBCA steering committee member and metastatic ILC advocate Elizabeth Viggiano will add the patient perspective.

This educational webinar is open to everyone interested in learning more about metastatic lobular breast cancer, regardless of stage.

 
When:  November 13, 2019 from 1 to 2 PM EST.
Register for the Webinar
LBCA Resource Library
The Lobular Breast Cancer Alliance has added three educational sessions to our online ILC resource library

Lobular Breast Cancer: An Evening of Learning hosted by the Cleveland Clinic features a panel answering patient questions about lobular breast cancer.  The ILC Lunch and Learn held at the 2019 Northwest Metastatic Breast Cancer Conference provides an overview of ILC with particular focus on metastatic disease.  The Advocate-led Roundtable Discussion co-hosted with SHARE Cancer Support provides a basic overview of ILC and reviews the role of advocacy to advance research and raise the profile of lobular breast disease.
Do you value LBCA's educational information and advocacy? 
Your contribution will support our work.  Please give today.  
Copyright © 2019 Lobular Breast Cancer Alliance (LBCA) - a project of Social and Environmental Entrepreneurs, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
View LBCA's privacy policy and terms of service on our website.

View this email in your browser

Email Marketing Powered by Mailchimp